Medicus Bets on Melanoma ADC After Pfizer Deal
Medicus has named its melanoma antibody-drug conjugate a 'strategic priority' after closing a deal with Pfizer, concentrating resources on the program.
Topic
Drug Development Pipeline
Topic
Drug Development Pipeline
ORKA Stock Falls 5% Despite Positive Week 28 Psoriasis Efficacy Data
ORKA shares fell roughly 5% the day of its Week 28 plaque psoriasis efficacy readout, per TradingView, a reminder that biotech ma…